Neoadjuvant Use of Isolated Limb Perfusion in Large Myxoid Liposarcoma of the Thigh : a Case Report
Large unresectable STS presents a therapeutic challenge. Several options are being explored to avoid amputation without compromising the oncological outcome. Neoadjuvant chemotherapy delivers inconsistent and rather unsatisfactory results, preoperative radiotherapy compromises healing, hence it can impede adjuvant systemic treatment. We present a case report of neoadjuvant use of isolated limb perfusion with TNF-alfa and Alkeran (Melphalan) in a patient with initially unresectable large myxoid liposarcoma of the thigh. We achieved 55% reduction in size of the tumor that allowed for wide resection with a safe margin. Pathology confirmed 99% tumor necrosis. The patient has a full function of his extremity and is disease-free at one year follow-up. ILP should be considered as a treatment option which, in selected cases, can contribute to limb sparing surgery. Key words: sarcoma, soft tissue, regional perfusion, chemotherapy, surgery, orthopedic, limb salvage.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca - 88(2021), 4 vom: 02., Seite 321-324 |
| Sprache: |
Tschechisch |
|---|
| Weiterer Titel: |
Neoadjuvantní užití izolované perfuze končetiny u objemného myxoidního liposarkomu stehna: kazuistika |
|---|
| Beteiligte Personen: |
Lesenský, J [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.09.2021 Date Revised 21.09.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM330760289 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330760289 | ||
| 003 | DE-627 | ||
| 005 | 20231225211957.0 | ||
| 007 | tu | ||
| 008 | 231225s2021 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330760289 | ||
| 035 | |a (NLM)34534063 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 100 | 1 | |a Lesenský, J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neoadjuvant Use of Isolated Limb Perfusion in Large Myxoid Liposarcoma of the Thigh |b a Case Report |
| 246 | 3 | 3 | |a Neoadjuvantní užití izolované perfuze končetiny u objemného myxoidního liposarkomu stehna: kazuistika |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 21.09.2021 | ||
| 500 | |a Date Revised 21.09.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Large unresectable STS presents a therapeutic challenge. Several options are being explored to avoid amputation without compromising the oncological outcome. Neoadjuvant chemotherapy delivers inconsistent and rather unsatisfactory results, preoperative radiotherapy compromises healing, hence it can impede adjuvant systemic treatment. We present a case report of neoadjuvant use of isolated limb perfusion with TNF-alfa and Alkeran (Melphalan) in a patient with initially unresectable large myxoid liposarcoma of the thigh. We achieved 55% reduction in size of the tumor that allowed for wide resection with a safe margin. Pathology confirmed 99% tumor necrosis. The patient has a full function of his extremity and is disease-free at one year follow-up. ILP should be considered as a treatment option which, in selected cases, can contribute to limb sparing surgery. Key words: sarcoma, soft tissue, regional perfusion, chemotherapy, surgery, orthopedic, limb salvage | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Vočka, M |e verfasserin |4 aut | |
| 700 | 1 | |a Špaček, M |e verfasserin |4 aut | |
| 700 | 1 | |a Hósová, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca |d 1950 |g 88(2021), 4 vom: 02., Seite 321-324 |w (DE-627)NLM000055905 |x 0001-5415 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2021 |g number:4 |g day:02 |g pages:321-324 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2021 |e 4 |b 02 |h 321-324 | ||